Absci partners with Oracle and AMD to accelerate AI drug discovery

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026


Go back to Absci partners with Oracle and AMD to accelerate AI drug discovery

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

September 11, 2025 8:00 AM UTC

Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs

AUSTIN, Texas and VANCOUVER, Washington, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Absci, a clinical-stage biotech company advancing novel therapeutics with generative AI, today announced a collaboration with... More